PRP, Exosomes and Low Level Laser: Which Non-Surgical Hair Treatments Are Worth Considering

Ask about thinning hair at a pharmacy counter, a cosmetic clinic or a Dublin hair loss clinic and the list of options you are offered has grown considerably in the past decade, most of it involving needles, light or vials rather than surgery. Platelet-rich plasma, exosome injections and low level laser devices now sit alongside the older topical and oral medicines, often at several hundred euro or pounds per session. The biology behind them is genuinely interesting. The evidence behind them is more uneven than the advertising suggests, and it is worth knowing which is which before committing to a course.

What platelet-rich plasma actually involves

PRP is a clinic procedure rather than a product you take home. Blood is drawn from the arm, usually between 10 and 60 millilitres depending on the protocol, and spun in a centrifuge to separate the plasma fraction containing a high concentration of platelets. That concentrate is injected into the scalp across the thinning area, typically in a grid of small injections a centimetre or so apart. Most people describe the injections as uncomfortable rather than painful. Clinics often use ice, vibration or a topical anaesthetic, and the appointment usually runs to under an hour.

Schedules vary, but a common pattern is three or four treatments spaced four to six weeks apart, then maintenance every four to six months. That structure matters financially. PRP is not a one-off purchase but an ongoing programme, and the effect, where it appears at all, fades once treatment stops. Side effects are generally limited to soreness, swelling and short-lived redness, since the material injected is the patient’s own blood.

What the evidence shows, and what it does not

There are dozens of published PRP studies and several meta-analyses, and the overall signal is mildly positive. A number of randomised trials report increases in hair density and thickness against placebo injections, usually measured over three to six months. That is not nothing. But the studies are small, often fewer than 40 participants, and follow-up is short.

The bigger problem is that PRP is not one thing. Preparation protocols differ in spin speed, spin time, whether an activating agent is added, and the final platelet concentration, which can vary several-fold between systems. Injection depth, volume and spacing differ too. When trials use different preparations, pooling them becomes shaky, and reviews tend to conclude that PRP shows promise while calling for standardised protocols. That caveat has been repeated for years and remains largely unaddressed.

A fair summary: PRP may produce a modest density improvement in people with early to moderate thinning who still have miniaturising hair to work with, results vary between individuals, and nobody should expect it to produce hair where the follicles have gone.

Exosomes and the regulatory question

Exosome products are the newer arrival: extracellular vesicles, usually derived from cultured stem cells, carrying proteins and genetic material thought to influence follicle signalling. The laboratory rationale is reasonable and the early data is not discouraging, but the published human evidence in hair loss consists largely of small case series and open-label studies rather than controlled trials.

Regulation is the sharper issue. In the European Union and the United Kingdom, products of this kind generally fall under medicines or advanced therapy rules rather than cosmetic or device rules, which means a licensed exosome treatment for hair loss is not something that currently exists on the ordinary market. Regulators including the US Food and Drug Administration have issued public warnings about unapproved exosome products marketed for hair and skin. A patient is entitled to ask what is in the vial, where it was produced and under what authorisation. The price is often high and the evidence supporting it is thinner than for PRP.

Laser caps, combs and helmets

Low level laser therapy, sometimes called photobiomodulation, uses red light at around 650 nanometres delivered by a cap, helmet or handheld comb, generally for 10 to 30 minutes several times a week. Several devices have regulatory clearance for this use, and the trial evidence, much of it sponsored by device manufacturers, does show small statistically significant increases in hair count against sham devices.

The effect size is modest, adherence over many months is the main determinant of whether anyone sees anything, and devices range from roughly 200 euro to well over 1,000. Safety is good. As a low-risk addition for someone already using medication, laser therapy is defensible. As a standalone plan for visible baldness, it is not.

The better-evidenced starting point

For pattern hair loss, topical and oral medicines remain the treatments with the largest and longest-running evidence base, including multi-year trials involving thousands of participants. They are the reasonable first line for most people, which is why any clinic that steers a patient straight into an injection course without discussing them is worth questioning. These are prescription or pharmacy medicines in most cases. They require proper medical assessment, they carry possible side effects that should be discussed frankly before starting, and they need to be continued for any benefit to be maintained. That conversation belongs with a doctor, not a website.

Where adjuncts genuinely fit

The most honest use of PRP, laser and similar treatments is as support for hair that still exists. Someone having a transplant has a finite donor supply, and the native hair around the grafts will carry on thinning unless something slows it down. Adjunct treatments are often used before and after surgery on that basis, to preserve existing coverage so the transplanted hair does not end up surrounded by fresh loss a few years later. Some surgeons also use PRP around the time of surgery in the hope of supporting graft recovery, though the evidence there is limited too.

What none of these treatments do is regrow hair on a smooth, fully bald scalp. Once follicles are gone, no injection or light source brings them back. Surgery remains the only method of moving hair into an area that has none.

Reading the marketing

Before and after photographs taken under different lighting, with wet versus dry hair, or from different angles are close to meaningless as evidence. Percentage claims quoted without a source, a sample size or a time frame are marketing rather than data. Language such as “clinically proven” attached to a brand name rather than to a published trial should prompt a request for the actual reference.

The useful question to put to any clinic is straightforward: what would you expect this to achieve in my case, over what period, and what happens if I stop. A practitioner who answers with specifics, including the honest possibility that little changes, is telling you more than any brochure will.

Link details for publication

Anchor text: Dublin hair loss clinic

Destination URL: https://www.totalhairrestoration.ie/dublin/

Placement: first paragraph of the article.